Covered recipient · General Payments record
LINH DANG
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$10,167.40
- Reported across 354 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $459.09 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $129.64 | 4 |
| ARGENX US, INC. | $121.84 | 1 |
| PFIZER INC. | $51.56 | 3 |
| ABBVIE INC. | $47.70 | 2 |
| Lundbeck LLC | $27.40 | 1 |
| Lilly USA, LLC | $26.19 | 1 |
| Biogen, Inc. | $24.50 | 1 |
| EISAI INC. | $21.45 | 1 |
| INSIGHTEC,INC | $8.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.54 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103598114 | CMS |
| ABBVIE INC. | $27.16 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103598116 | CMS |
| ARGENX US, INC. | $121.84 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142116785 | CMS |
| Biogen, Inc. | $24.50 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104830074 | CMS |
| Eisai Inc. | $21.45 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110760760 | CMS |
| InSightec,Inc | $8.81 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110445415 | CMS |
| Lilly USA, LLC | $26.19 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135143797 | CMS |
| Lundbeck LLC | $27.40 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145908487 | CMS |
| Neurocrine Biosciences, Inc. | $37.30 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150816756 | CMS |
| Neurocrine Biosciences, Inc. | $30.07 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150825788 | CMS |
| Neurocrine Biosciences, Inc. | $30.57 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150825006 | CMS |
| Neurocrine Biosciences, Inc. | $31.70 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150823235 | CMS |
| PFIZER INC. | $23.83 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130956350 | CMS |
| PFIZER INC. | $13.61 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131219963 | CMS |
| PFIZER INC. | $14.12 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131878464 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.